Ascending Single-Dose and Multiple-Dose Study to Evaluate RJ4287 in Healthy Subjects
Clinical trial NCT05921006 · UNKNOWN
Trial details
- NCT number
- NCT05921006
- Sponsor
- Nanjing Ruijie Pharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-13
- Primary completion
- 2023-12-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.